(KIN) - Earnings & Price History

KIN: - 7.2, $207.39M, -0.25 (-3.36%)

Sector: Healthcare - Industry: Biotechnology

Kindred Biosciences, Inc., a development stage biopharmaceutical company, focuses on the development of therapies for pets. The companys product pipeline consists of small molecules and biologics for a range of indications in dogs, cats, and horses. Its lead product candidates include Zimeta, a pyrazolone anti-inflammatory drug, for the treatment of fever in horses; and KIND-010 for management of weight loss in cats and feline epo for anemia in cats. The company's other small molecule product candidates consist of KIND-014 for treatment of equine gastric ulcer syndrome; and KIND-015 for the treatment of metabolic syndrome in horses. It is also developing biologics products, such as KIND-510, a feline erythropoeitin for treatment of anemia in cats; KIND-502 for the treatment of allergic and immune-mediated diseases; KIND-0888, an antibody that targets CD20; various antibodies that target

Past KIN reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2017-03-01AMC-0.365.955.355.35.36.05-0.93%12.26%11.21%76.74K
2016-11-07AMC-0.335.355.15.155.065.40.98%▲3.88%4.90%44.80K
2016-08-08AMC-0.323.9753.9554.063.864.0652.65%-2.09%0.51%117.26K
2016-05-05AMC-0.323.323.363.353.123.39-0.30%-0.90%-1.19%64.47K
2016-03-02AMC-0.443.763.814.133.754.138.40%-8.96%-1.31%119.71K
2015-11-09-0.445.6655.535.545.545.850.18%▲2.26%2.44%6.47K
2015-08-10-0.446.076.066.0366.27-0.50%0.66%0.17%19.79K
2015-05-08-0.41
2014-11-13AMCKindred Biosci-0.318.748.989.168.729.162.00%▲-4.59%-2.67%52.60K
2014-08-13AMCKindred Biosci-0.35-0.4215.1215.8215.6714.9615.67-0.95%-3.51%-4.42%56.90K
2014-05-12AMCKindred Biosci-0.18-0.3815.0316.6316.5214.816.54-0.66%-9.02%-9.62%204.70K
2014-03-06AMCKindred Biosci-0.19-0.424.5824.582322.224.99-6.43%6.87%170.30K

Login | Register
Sunday Dec 16, 2018   EST
Enter a Ticker:

Economic Calendar

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY257.6450.500.19%41,867,194

Upgrades/Downgrades